Skip to main content

Table 3 Proportion of patients achieving HbA1c less than 7%

From: Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study

Ā  Follow-up A1cā€‰<ā€‰7% Total p (2-sided)
No Yes
Cohort Dulaglutide Number of Patients 21 9 30 0.019
% 70.0% 30.0% 100.0%
Liraglutide Number of Patients 11 19 30
% 36.7% 63.3% 100.0%
Total Number of Patients 32 28 60
% 53.3% 46.7% 100.0%